Increasing Regulatory Approvals to Promote Development of Advanced Proton Therapy Systems

Proton therapy system is used to destroy all the viable cancer cells. Therefore, increasing number of cancer cases worldwide is expected to rev up the adoption of proton therapy systems. The American Cancer Society estimates 1,688,780 new cancer cases to be diagnosed in the U.S. in 2017. According to its study, cancer is estimated to cause about 600,920 deaths in the same year.

Proton therapy system consists of radiation devices, wherein accelerated protons act as a source of radiation. A typical system includes electromagnets, patient room, accelerator, gantry, and nozzle. Accelerators are used to target tumors with a proton beam. Protons can interfere with cell DNA, thus damaging the cell and leading to its death.

Cost-effective Proton Therapy System

Regulatory approvals of products are not only beneficial to their manufacturers, but they also ensure availability of advanced technologies to end users. For instance, in December 2016, ProNova Solutions received an FDA 510(k) clearance for its SC360 proton therapy system. The system can offer modern technology and is smaller, lighter, and easier to install. It can also provide improved treatment at a lower cost, making it more accessible to cancer patients worldwide. It uses proprietary superconducting technology such as advanced cone beam CT imaging and pencil beam scanning.

Market Insights

Growing number of proton therapy centers coupled with increasing investments by hospitals to establish them can provide a significant upthrust to the global proton therapy systems market. Besides this, market participants such as manufacturers, hospitals, and private investors are allocating hefty funds that can be used in the development of low-cost and technologically advanced systems. This, in turn, is likely to positively impact the market.

Improving healthcare infrastructure along with rising healthcare expenditure by people, especially living in emerging nations, is poised to stoke the market growth. On the other hand, high cost involved in the establishment of proton therapy centers is estimated to dampen the upward climb of the market. This can be further exacerbated by lack of reimbursement policies in developing countries, finds Grand View Research, Inc.

Competitive Landscape

Proton therapy system manufacturers are partnering with other manufacturers to develop technologically advanced products. This will help them in enhancing their visibility in the market. Some of the key players in the market are Mevion Medical Systems, ProTom International, Mitsubishi Corporation, Hitachi Ltd., and ProNova Solutions LLC.

In-Depth research report on Proton Therapy Systems Market:

https://www.grandviewresearch.com/industry-analysis/proton-therapy-systems-market